We aimed to analyze how MMR deficiency influences mutational events in incident cancers and studied MMR deficiency signatures, namely the presence of C > T transitions at CpG sites and insertion/deletion (indel) mutations in APC and KRAS mutations observed in incident cancers, and compared these to previous sequencing results obtained from prevalent CRC [32,38,51]. This evidence concerns the gene KRAS and cancer.